EUVIMEDEUVIMED entdecken
Crossref

Optimizing Transfection Efficiency in CAR-T Cell Manufacturing through Multiple Administrations of Lipid-Based Nanoparticles

Francesca Giulimondi, Luca Digiacomo, Serena Renzi, Chiara Cassone, Andrea Pirrottina, Rosa Molfetta, Ilaria Elena Palamà iD, Gabriele Maiorano, Giuseppe Gigli, Heinz Amenitsch, Daniela Pozzi, Alessandra Zingoni und 1 weitere

ACS Applied Bio Materials · 2024

DOI: 10.1021/acsabm.4c00103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2024. Verfasst von Francesca Giulimondi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Sapienza University of Rome, V.le Regina Elena 291, Rome 00161, Italy. Hauptthemen laut MEDLINE: Transfection, Nanoparticles, Lipids, Materials Testing. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Ministero dell'Universit? e della Ricerca, Regione Puglia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The existing manufacturing protocols for CAR-T cell therapies pose notable challenges, particularly in attaining a transient transfection that endures for a significant duration. To address this gap, this study aims to formulate a transfection protocol utilizing multiple lipid-based nanoparticles (LNPs) administrations to enhance transfection efficiency (TE) to clinically relevant levels. By systematically fine-tuning and optimizing our transfection protocol through a series of iterative refinements, we have accomplished a remarkable one-order-of-magnitude augmentation in TE within the immortalized T-lymphocyte Jurkat cell line. This enhancement has been consistently observed over 2 weeks, and importantly, it has been achieved without any detrimental impact on cell viability. In the subsequent phase of our study, we aimed to optimize the gene delivery system by evaluating three lipid-based formulations tailored for DNA encapsulation using our refined protocol. These formulations encompassed two LNPs constructed from ionizable lipids and featuring systematic variations in lipid composition (iLNPs) and a cationic lipoplex (cLNP). Our findings showcased a notable standout among the three formulations, with cLNP emerging as a frontrunner for further refinement and integration into the production pipeline of CAR-T therapies. Consequently, cLNP was scrutinized for its potential to deliver CAR-encoding plasmid DNA to the HEK-293 cell line. Confocal microscopy experiments demonstrated its efficiency, revealing substantial internalization compared to iLNPs. By employing a recently developed confocal image analysis method, we substantiated that cellular entry of cLNP predominantly occurs through macropinocytosis. This mechanism leads to heightened intracellular endosomal escape and mitigates lysosomal accumulation. The successful expression of anti-CD19-CD28-CD3z, a CAR engineered to target CD19, a protein often expressed on the surface of B cells, was confirmed using a fluorescence-based assay. Overall, our results indicated the effectiveness of cLNP in gene delivery and suggested the potential of multiple administration transfection as a practical approach for refining T-cell engineering protocols in CAR therapies. Future investigations may focus on refining outcomes by adjusting transfection parameters like nucleic acid concentration, lipid-to-DNA ratio, and incubation time to achieve improved TE and increased gene expression levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TransfectionNanoparticlesLipidsMaterials TestingParticle SizeHumansJurkat CellsBiocompatible MaterialsCell SurvivalDNAT-LymphocytesReceptors, Chimeric Antigen

Stichwörter der Autor:innen

CAR-Tcell transfectiongene deliverylipid nanoparticleslipoplexes

Substanzen

LipidsBiocompatible MaterialsDNAReceptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Molecular Medicine, Sapienza University of Rome, V.le Regina Elena 291, Rome 00161, Italy.
  • Nanotechnology Institute, CNR-NANOTEC, Via Monteroni, Lecce 73100, Italy.
  • Department of Medicine, University of Salento, Arnesano street c/o Campus Ecotekne, Lecce 73100, Italy.
  • Institute of Inorganic Chemistry, Graz University of Technology, Graz 8010, Austria.

ORCID-Profile: Ilaria Elena Palamà, Giulio Caracciolo

Förderung

  • Ministero dell'Universit? e della Ricerca
  • Regione Puglia

Zitieren

APA

Giulimondi, F., Digiacomo, L., Renzi, S., Cassone, C., Pirrottina, A., Molfetta, R., Palamà, I. E., Maiorano, G., Gigli, G., Amenitsch, H., Pozzi, D., Zingoni, A., & Caracciolo, G. (2024). Optimizing Transfection Efficiency in CAR-T Cell Manufacturing through Multiple Administrations of Lipid-Based Nanoparticles. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.4c00103

Vancouver

Giulimondi F, Digiacomo L, Renzi S, Cassone C, Pirrottina A, Molfetta R, et al. Optimizing Transfection Efficiency in CAR-T Cell Manufacturing through Multiple Administrations of Lipid-Based Nanoparticles. ACS Applied Bio Materials. 2024. doi:10.1021/acsabm.4c00103

BibTeX
@article{Giulimondi2024,
  author = {Giulimondi, Francesca and Digiacomo, Luca and Renzi, Serena and Cassone, Chiara and Pirrottina, Andrea and Molfetta, Rosa and Palamà, Ilaria Elena and Maiorano, Gabriele and Gigli, Giuseppe and Amenitsch, Heinz and Pozzi, Daniela and Zingoni, Alessandra and Caracciolo, Giulio},
  title = {Optimizing Transfection Efficiency in CAR-T Cell Manufacturing through Multiple Administrations of Lipid-Based Nanoparticles},
  journal = {ACS Applied Bio Materials},
  year = {2024},
  doi = {10.1021/acsabm.4c00103}
}
Kostenlos starten →